Bill > HB0182

This bill establishes new regulations for medical and genomic research facilities regarding the use and storage of genetic information, defining terms like "DNA" (deoxyribonucleic acid), "foreign adversary" (as identified by federal regulations), "genetic sequencer" (devices for analyzing genetic material), and "human genome" (an individual's complete genetic makeup). It prohibits these facilities from using genetic sequencers or related software produced by or distributed from foreign adversaries, requiring them to remove or disable any prohibited equipment and use compliant alternatives. Furthermore, it restricts the storage of genetic sequencing data, other than publicly available "open data," within foreign adversary territories and mandates secure storage practices, such as encryption, for non-open data, with an exemption for certain clinical trial data. Facilities must submit sworn statements confirming compliance by December 31, 2028, and every ten years thereafter, and violations can result in fines of $10,000 per instance, with enforcement beginning May 1, 2028. The Attorney General is solely responsible for enforcing these provisions, with the ability to pursue civil actions and recover damages, costs, attorney fees, and fines. The bill also protects employees from adverse employment actions if they report violations.